Arun Tholudur is an Executive Director of Process Development at Amgen where he leads the Drug Substance Technologies and Engineering organization that is accountable for ensuring successful implementation of multi-modality drug substance processes in the GMP environment from first-in-human clinical to commercial manufacturing across Amgen's internal and external manufacturing network. The team’s responsibilities span technology transfer, process validation, process monitoring, regulatory submission authoring and inspection support, continued process optimization for yield and...Read more
